Radiotherapy Outcomes in Solitary Plasmacytoma with High-Risk Cytogenetic Abnormalities

被引：0
|
作者：
Frechette, K. M. [1 ]
Day, C. N. [2 ]
Lucido, J. [1 ]
Zhang, H. [3 ]
Thull, J. C. [1 ]
Yadav, U. [4 ]
Hoppe, B. S. [5 ]
Peterson, J. L. [5 ]
Rule, W. G. [6 ]
Lester, S. C. [1 ]
Kumar, S. [4 ]
Buadi, F. [4 ]
Gonsalves, W. I. [3 ]
Breen, W. [1 ]
机构：
[1] Mayo Clin, Dept Radiat Oncol, Rochester, MN USA
[2] Mayo Clin, Dept Biomed Stat & Informat, Rochester, MN USA
[3] Mayo Clin, Rochester, MN USA
[4] Mayo Clin, Dept Hematol, Rochester, MN USA
[5] Mayo Clin, Dept Radiat Oncol, Jacksonville, FL 32224 USA
[6] Mayo Clin, Dept Radiat Oncol, Phoenix, AZ USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2024年 / 120卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3366
引用
收藏
页码：E623 / E623
页数：1
相关论文
共 50 条
  • [31] Radiotherapy-resistant solitary bone plasmacytoma of the clavicle
    Panagopoulos A.
    Megas P.
    Kaisidis A.
    Dimakopoulos P.
    European Journal of Trauma, 2006, 32 (2): : 190 - 193
  • [32] Radiotherapy-based approach for the treatment of solitary plasmacytoma
    Alghisi, A.
    Borghetti, P.
    Maddalo, M.
    Roccaro, A. M.
    Tucci, A.
    Magrini, S. M.
    Lo Casto, A.
    Bonu, M. L.
    Tomasini, D.
    Baiguini, A.
    Peretto, G.
    Buglione, M.
    Triggiani, L.
    RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S489 - S490
  • [33] Benefits of radiotherapy for patients with solitary plasmacytoma or multiple myeloma
    Koenig, Laila
    Herfarth, Klaus
    RADIOLOGE, 2022, 62 (01): : 30 - 34
  • [34] Solitary Plasmacytoma of the Penile Urethra Treated With Primary Radiotherapy
    Alcorn, Sara R.
    Gocke, Christopher D.
    Woodard, Christopher A.
    Tran, Phuoc T.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (28) : E95 - E97
  • [35] Radiotherapy for solitary plasmacytoma and multiple myeloma in the current era
    Kaufmann, Justus
    Schmidberger, Heinz
    ONKOLOGIE, 2024, : 401 - 405
  • [36] Radiotherapy for the treatment of solitary plasmacytoma: 7-year outcomes by a mono-institutional experience
    Alessandro Alghisi
    Paolo Borghetti
    Marta Maddalo
    Aldo Maria Roccaro
    Alessandra Tucci
    Rosario Mazzola
    Stefano Maria Magrini
    Antonio Lo Casto
    Marco Lorenzo Bonù
    Davide Tomasini
    Nadia Pasinetti
    Gloria Peretto
    Francesco Bertagna
    Cesare Tomasi
    Michela Buglione
    Luca Triggiani
    Journal of Cancer Research and Clinical Oncology, 2021, 147 : 1773 - 1779
  • [37] Radiotherapy for the treatment of solitary plasmacytoma: 7-year outcomes by a mono-institutional experience
    Alghisi, Alessandro
    Borghetti, Paolo
    Maddalo, Marta
    Roccaro, Aldo Maria
    Tucci, Alessandra
    Mazzola, Rosario
    Magrini, Stefano Maria
    Lo Casto, Antonio
    Bonu, Marco Lorenzo
    Tomasini, Davide
    Pasinetti, Nadia
    Peretto, Gloria
    Bertagna, Francesco
    Tomasi, Cesare
    Buglione, Michela
    Triggiani, Luca
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2021, 147 (06) : 1773 - 1779
  • [38] High risk cytogenetic abnormalities in patients with multiple myeloma
    Eugenia Legues, Maria
    Morales, Paulina
    Valenzuela, Mercedes
    Encina, Andrea
    Jose Marti, Maria
    Bascunan, Claudia
    Cornejo, Paulina
    Pena, Camila
    Soledad Undurraga, Maria
    REVISTA MEDICA DE CHILE, 2019, 147 (01) : 61 - 64
  • [39] Autologous stem cell transplantation in patients with high-risk plasmacytoma
    Jantunen, E
    Koivunen, E
    Putkonen, M
    Siitonen, T
    Juvonen, E
    Nousiainen, T
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2005, 74 (05) : 402 - 406
  • [40] Outcomes after adjuvant sequential chemotherapy and radiotherapy for high-risk endometrial cancer
    Fullerton, R.
    Zahra, M.
    Stille, A.
    Morgan, J.
    RADIOTHERAPY AND ONCOLOGY, 2023, 182 : S1159 - S1160
12345